Braun Stacey Associates’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Sell
28,750
-38,679
-57% -$3.71M 0.09% 91
2025
Q4
$6.26M Sell
67,429
-138,490
-67% -$15.1M 0.2% 86
2025
Q3
$25.6M Sell
205,919
-11,185
-5% -$1.42M 0.84% 46
2025
Q2
$28.6M Sell
217,104
-458
-0.2% -$51.8K 1.03% 26
2025
Q1
$22.8M Buy
217,562
+793
+0.4% +$83K 0.93% 46
2024
Q4
$23.5M Sell
216,769
-1,640
-0.8% -$183K 0.88% 43
2024
Q3
$23.3M Sell
218,409
-21,906
-9% -$2.22M 0.89% 45
2024
Q2
$23.8M Sell
240,315
-15,182
-6% -$1.53M 0.92% 41
2024
Q1
$23.6M Buy
255,497
+39,309
+18% +$3.17M 0.94% 45
2023
Q4
$16.3M Buy
216,188
+126,328
+141% +$8.22M 0.73% 63
2023
Q3
$5.44M Buy
+89,860
New +$6.17M 0.27% 89

Other funds holding ITRI

Braun Stacey Associates's ITRI Position: Q1 2026 in Review

Braun Stacey Associates reduced its Itron (ITRI) stake by 57% in Q1 2026, selling an estimated $3.71M and leaving 28,750 shares worth $2.58M. The position accounts for 0.09% of the portfolio, ranked #91.

Braun Stacey Associates first reported a position in ITRI in Q3 2023 and has held it in 11 quarters since. The position peaked at $28.6M in Q2 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Braun Stacey Associates held 28,750 shares of Itron worth $2.58M as of Q1 2026.
  • Braun Stacey Associates sold 38,679 Itron shares in Q1 2026, an estimated $3.71M.
  • Itron made up 0.09% of Braun Stacey Associates's portfolio in Q1 2026, its #91 holding.
  • Braun Stacey Associates first reported a position in Itron in Q3 2023 and has held it in 11 quarters since.
  • Braun Stacey Associates's Itron position peaked at $28.6M in Q2 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.